Skip to main content
. 2019 Jul 4;9:9647. doi: 10.1038/s41598-019-46250-4

Figure 4.

Figure 4

Increase in plasma membrane surface localization of the D97S mutant by endocytosis inhibitor or primaquine treatment. (A,B) MDCK cells stably expressing the FLAG-tagged D97S mutant were treated with MDC and MβCD for 3 h. After collecting cell lysates, the aliquots were blotted with anti-FLAG and anti-β-actin antibodies. The band densities of proteins are represented relative to the values with 0 μM. (B) The cells were stained with anti-FLAG (CLDN16) and anti-ZO-1 antibodies. (C,D) MDCK cells stably expressing the FLAG-tagged D97S mutant were incubated with primaquine (PQ, 100 μM). The biotinylated proteins were blotted with anti-FLAG and anti-CLDN1 antibodies. (E) The cell lysates of MDCK cells expressing the WT or D97S mutant were blotted with anti-FLAG and anti-β-actin antibodies. The band densities of proteins are represented relative to the values at 0 h. The full-length blot images are shown in Supplementary Figs S6S8. (F) The cells were incubated with anti-FLAG (CLDN16) and anti-ZO-1 antibodies. The scale bar indicates 10 μm. n = 4 in four independent experiments. **P < 0.01 and *P < 0.05 compared with 0 μM.